Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis

Journal of Infection in Developing Countries

Volumn 9, Issue 4, 2015, Pages 435-437

  Kumar, Dharmendra ^a   Banerjee, Tuhina ^a   Pratap, Chandra Bhan ^a   Tilak, Ragini ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

C. auris; Non albicans; Phospholipase; Resistance

Indexed keywords

AMPHOTERICIN B; DNA 18S; FLUCONAZOLE; HEMOLYSIN; ITRACONAZOLE; PHOSPHOLIPASE; PROTEINASE; VORICONAZOLE; ANTIFUNGAL AGENT; FUNGAL DNA; PEPTIDE HYDROLASE; RIBOSOMAL SPACER DNA; VIRULENCE FACTOR;

ADULT; ANTIFUNGAL RESISTANCE; ARTICLE; CANDIDA; CANDIDA AURIS; CASE REPORT; CONTROLLED STUDY; DISK DIFFUSION; DYSPAREUNIA; ENZYME ACTIVITY; FEMALE; HUMAN; INTERNAL TRANSCRIBED SPACER POLYMERASE CHAIN REACTION; LOW BACK PAIN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRURITUS; VAGINA DISCHARGE; VULVOVAGINITIS; CANDIDIASIS, VULVOVAGINAL; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; TREATMENT OUTCOME;

CANDIDA; CANDIDA ALBICANS;

ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HEMOLYSIN PROTEINS; HUMANS; ITRACONAZOLE; MICROBIOLOGICAL TECHNIQUES; PEPTIDE HYDROLASES; PHOSPHOLIPASES; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; VIRULENCE FACTORS;

EID: 84927932458     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.4582     Document Type: Article

References (11)

1. Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H (2009) Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 53: 41-44
2. Mohanty S, Xess I, Hasan F, Kapil A, Mittal S, Jorge E (2007) Prevalence & susceptibility to fluconazole of Candida species causing vulvovaginitis. Indian J Med Res126: 216-19.
3. Nadagir SD, Chunchanur SK, Halesh LH, Yasmeen K, Chandrashakhar MR, Patil B (2008) Significance of Isolation And Drug Susceptibility Testing Of Non-Candida albicans Species Causing Oropharyngeal Candidiasis In HIV Patients. Southeast Asian J Trop Med Public Health39: 492-495
4. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A2. 2nd ed. Wayne, PA: CLSI, 2002.
5. Mahmoudi Rad M, Zafarghandi ASh, Amel Zabihi M, Tavallaee M, Mirdamadi Y (2012) Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. Infect Dis Obstet Gynecol 2012: 872169.
6. Tsang CSP, Chu FCS, Leung WK, Jin LJ, Samaranayake LP, Siu SC (2007) Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol 56: 1393-1398
7. Sobel JD (1997) Vaginitis. N Eng J Med 337: 1896-1903
8. Ferrer J (2000) Vaginal candidosis: epidemiological and etiological factors. Int J Gynecol Obstet 71: 21-7.
9. Sarma S, Kumar N, Sharma S, Govil D, Ali T, Mehta Y, Rattan A (2013) Candidemia caused by amphotericin B and fluconazole resistant Candida auris. Indian J Med Microbiol 31: 90-101
10. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW (2009) Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungalsusceptibility, and clinical features. Clin Infect Dis48: e57-61
11. Lee WK,Shin JH,Kang MG,Kim SH,Park KH,Jang H (2011)First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol 49: 3139-3142